-
Page avancée | 2024.11.20
Coupa, the supplier relations tool
Institut Pasteur uses Coupa, an expense and procurement management tool, designed to offer its users and suppliers a flexible and secure exchange platform.
-
News | 2024.12.16
Microbiota tailored skin humoral immunity and its potential for the development of novel vaccinal approaches
Scientists have just made two major discoveries about a harmless bacterium, Staphylococcus epidermidis, present on our skin. A first study identifies the skin as a compartment able to develop highly protective antibody responses to skin colonizing microbe in the absence of inflammation or lymph node contribution. A second study concerns the development of a topical vaccine that can be applied...
-
News | 2024.10.23
Talent Award: Claire Sangba-Kembi-Ngounou, 2024 winner
Dr. Claire Sangba-Kembi-Ngounou, entomologist at the Institut Pasteur in Bangui (Central African Republic), receives the Talent Award. This award highlights young Pasteur Network researchers who have demonstrated scientific potential. The Talent Award is funded since 2017 by the Institut Pasteur (Paris).
-
News | 2024.12.11
An Inaugural Ceremony to Honor Agnes Ullmann, an Exceptional Scientist and Key Figure in Education at the Institut Pasteur
On December 11, 2024, a symbolic and historic inaugural event took place to pay tribute to Agnes Ullmann, an iconic scientific figure at the Institut Pasteur, celebrating her legacy both as a renowned researcher and as a prominent personality who left her mark on scientific education, research, and innovation within the institution. Dozens of guests, including friends, colleagues,...
-
News | 2024.12.20
Signing of a Memorandum of Understanding between the Institut Pasteur and the International Vaccine Institute (IVI)
The Institut Pasteur and the International Vaccine Institute (IVI) are strengthening their commitment to global health by signing a Memorandum of Understanding (MoU), marking a new milestone in their collaboration. The official ceremony took place on December 19, 2024, on the Institut Pasteur campus in Paris, in the presence of Yasmine Belkaid, Director General of the Institut Pasteur, and Dr....
-
Page avancée | 2021.01.26
Our governance
With an effective management policy and successful response strategy, the Management, Board of Directors and General Meeting board provide the impetus for the Institut Pasteur’s research.
-
News | 2024.12.03
The essential role of the gene Nr5a2 in embryogenesis
Scientists have elucidated the role of the gene Nr5a2 in the first stages of embryonic development in mammals. This research sheds new light on a biological process that is not yet fully understood.
-
Fiche maladie | 2018.12.05
Cholera
Cholera is an epidemic acute diarrheal disease that only affects humans and is caused by serogroup O1 (and in rare cases O139) of the Vibrio cholerae bacterium. Although this infection is sometimes caused by direct contact with infected individuals (e.g. through unwashed hands, last offices, etc.), it is more commonly attributable to the ingestion of water or food contaminated with the feces of...
-
News | 2024.12.19
Paratyphoid B fever: tracing the history of the disease to improve surveillance
Paratyphoid B fever is caused by pathogenic bacteria of the species Salmonella enterica, serotype Paratyphi B. In Europe, the disease was most prevalent in the 20th century, so it has not been widely studied using modern techniques. Scientists from the Institut Pasteur have made new findings after studying more than 500 strains of the bacteria isolated since 1898, from human and animal infections...
-
Vidéo | 2025.01.02
Why do our brains love bubbles?
This festive season, bubbles are everywhere: in champagne, sodas and sparkling water. But do you know why they fascinate us so much?Gabriel Lepousez, a neuroscientist at the Institut Pasteur, sheds some light on this phenomenon, which combines our five senses and our emotions.For the past ten years, Gabriel has been exploring the workings of the olfactory system to understand how we perceive and...
